Michael J. LaBarre
Overview
Michael J. LaBarre received an average of $1M in total compensation, including $317K in salary, at Halozyme Therapeutics from 2008 to 2021.
2021Halozyme TherapeuticsSenior Vice President, Chief Technical Officer
2020Halozyme TherapeuticsSenior Vice President, Chief Technical Officer
2010Halozyme TherapeuticsVice President, Product Development
2009Halozyme TherapeuticsVice President, Product Development
2008Halozyme TherapeuticsVice President, Product Development
Source: SEC filings on March 25, 2022, March 26, 2021, and March 24, 2011.
Related executives
We found 21 more executives who work or worked at Halozyme Therapeutics.
Helen Torley
Halozyme Therapeutics
Chief Executive Officer
Masaru Matsuda
Halozyme Therapeutics
General Counsel
Elaine Sun
Halozyme Therapeutics
Chief Financial Officer
Laurie Stelzer
Halozyme Therapeutics
Chief Financial Officer
Alison Armour
Halozyme Therapeutics
Former Senior Vice President, Head of Research & Development
Benjamin Hickey
Halozyme Therapeutics
Former Senior Vice President, Chief Commercial Officer
Harry Leonhardt
Halozyme Therapeutics
General Counsel
Dimitrios Chondros
Halozyme Therapeutics